Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_71226
http://purl.obolibrary.org/obo/CHEBI_71226
|
|---|---|
| Preferred Name | telavancin |
| Synonyms |
C80H107Cl3N11O27P
Td 6424
C80H106C12N11O27P.(HCl)n
Vibativ
(1S,2R,18R,19R,22S,25R,28R,40S)-22-(carbamoylmethyl)-5,15-dichloro-48-{[(2S,3R,4S,5S,6R)-3-{[(2S,4S,5S,6S)-4-{[2-(decylamino)ethyl]amino}-5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,18,32,35,37-pentahydroxy-19-[(2R)-4-methyl-2-(methylamino)pentanamido]-20,23,26,42,44-pentaoxo-36-{[(phosphonomethyl)amino]methyl}-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2?,?.2??,??.1?,??.1??,??.0??,??.0??,??]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid hydrochloride
telavancin hydrochloride
Td-6424
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | telavancin
|
|---|---|
| label |
telavancin
telavancin hydrochloride
|
| DBSynonym | td-6424
|
| ATCCode | J01XA03
|
| Definition | Telavancin is a semi-synthetic derivative of vanocymycin that has bactericidal activity against Methicillin-resistant Staphylococcus aureus (MRSA is an important pathogen causing hospital-acquired pneumonia (HAP) worldwide) and other gram-positive bacteria. FDA approved on September 11, 2009.
A hydrochloride obtained by combining telavancin and hydrochloric acid. The composition of the compound is telavancin.nHCl where n = 1-3. Used for treatment of adults with complicated skin and skin structure infections caused by bacteria.
|
| DBSalt | telavancin hydrochloride
|
| type | |
| has role | |
| InChIKey | InChIKey=GSSIWSIRBWAZHG-ACOPVEIWSA-N
|
| AHFScode | 8:12.28.16
|
| Synonym | C80H107Cl3N11O27P
Td 6424
C80H106C12N11O27P.(HCl)n
Vibativ
(1S,2R,18R,19R,22S,25R,28R,40S)-22-(carbamoylmethyl)-5,15-dichloro-48-{[(2S,3R,4S,5S,6R)-3-{[(2S,4S,5S,6S)-4-{[2-(decylamino)ethyl]amino}-5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,18,32,35,37-pentahydroxy-19-[(2R)-4-methyl-2-(methylamino)pentanamido]-20,23,26,42,44-pentaoxo-36-{[(phosphonomethyl)amino]methyl}-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2?,?.2??,??.1?,??.1??,??.0??,??.0??,??]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid hydrochloride
telavancin hydrochloride
Td-6424
See more
See less
|
| xref |
CiteXplore:18985183
CiteXplore:16894408
CiteXplore:17073522
CiteXplore:20140276
CASRN:560130-42-9
RxList:http://www.rxlist.com/vibativ-drug.htm
CiteXplore:19088949
CiteXplore:22095816
CiteXplore:20199969
National Drug Code Directory:0469-3575-50
Reaxys:9988179
Wikipedia:http://en.wikipedia.org/wiki/Telavancin
CiteXplore:20644442
CiteXplore:21137625
CiteXplore:18850047
CiteXplore:20208468
Drugs.com:http://www.drugs.com/cdi/telavancin.html
CiteXplore:22095369
ChEBI:71226
CiteXplore:15834452
CiteXplore:21572764
CiteXplore:14576125
KEGG DRUG:D06057
CiteXplore:20401351
See more
See less
|
| prefixIRI | obo2:CHEBI_71226
|
| SMILES | Cl.CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=CC=C(C=C2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC=C(O)C(=C4)C4=C(C=C(O)C(CNCP(O)(O)=O)=C4O)[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O
|
| may interact with |
See more
See less
|
| InChI | InChI=1S/C80H106Cl2N11O27P.ClH/c1-7-8-9-10-11-12-13-14-21-85-22-23-87-80(5)32-57(115-37(4)71(80)103)119-70-68(102)67(101)55(34-94)118-79(70)120-69-53-28-41-29-54(69)117-52-20-17-40(27-46(52)82)65(99)63-77(109)91-61(78(110)111)43-30-50(96)44(33-86-35-121(112,113)114)66(100)58(43)42-25-38(15-18-49(42)95)59(74(106)93-63)90-75(107)60(41)89-73(105)48(31-56(83)97)88-76(108)62(92-72(104)47(84-6)24-36(2)3)64(98)39-16-19-51(116-53)45(81)26-39;/h15-20,25-30,36-37,47-48,55,57,59-65,67-68,70-71,79,84-87,94-96,98-103H,7-14,21-24,31-35H2,1-6H3,(H2,83,97)(H,88,108)(H,89,105)(H,90,107)(H,91,109)(H,92,104)(H,93,106)(H,110,111)(H2,112,113,114);1H/t37-,47+,48-,55+,57-,59+,60+,61-,62+,63-,64+,65+,67+,68-,70+,71+,79-,80-;/m0./s1
|
| DBBrand | vibativ
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |